Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Actuate Therapeutics, Inc. (ACTU) had Return on Investments of -49.45% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-5.41M |
|
-- |
|
-- |
|
$5.47M |
|
$-5.47M |
|
$0.06M |
|
$-5.41M |
|
$-5.41M |
|
$-5.41M |
|
$-5.41M |
|
$-5.41M |
|
$-5.41M |
|
$-5.47M |
|
$-5.47M |
|
21.39M |
|
21.39M |
|
$-0.25 |
|
$-0.25 |
|
| Balance Sheet Financials | |
$17.44M |
|
-- |
|
$0.27M |
|
$17.71M |
|
$6.37M |
|
-- |
|
$0.41M |
|
$6.78M |
|
$10.94M |
|
$10.94M |
|
$10.94M |
|
23.24M |
|
| Cash Flow Statement Financials | |
$-15.47M |
|
-- |
|
$23.75M |
|
$8.64M |
|
$16.92M |
|
$8.28M |
|
$4.50M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.74 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-15.47M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-49.45% |
|
-49.45% |
|
-30.53% |
|
|
Return on Investments |
-49.45% |
$0.47 |
|
$-0.72 |
|
$-0.72 |
|